1. Home
  2. HCAT vs ACOG Comparison

HCAT vs ACOG Comparison

Compare HCAT & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Health Catalyst Inc

HCAT

Health Catalyst Inc

HOLD

Current Price

$1.62

Market Cap

152.1M

Sector

Technology

ML Signal

HOLD

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

HOLD

Current Price

$5.95

Market Cap

129.4M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
HCAT
ACOG
Founded
2008
2000
Country
United States
Canada
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Sector
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
152.1M
129.4M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
HCAT
ACOG
Price
$1.62
$5.95
Analyst Decision
Hold
Strong Buy
Analyst Count
11
1
Target Price
$4.25
$18.00
AVG Volume (30 Days)
924.9K
74.2K
Earning Date
04-08-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
44.98
N/A
EPS
N/A
N/A
Revenue
$306,584,000.00
N/A
Revenue This Year
$3.30
N/A
Revenue Next Year
N/A
$132.35
P/E Ratio
N/A
N/A
Revenue Growth
3.60
N/A
52 Week Low
$1.67
$3.75
52 Week High
$5.06
$10.88

Technical Indicators

Market Signals
Indicator
HCAT
ACOG
Relative Strength Index (RSI) 32.40 56.02
Support Level N/A $4.96
Resistance Level $2.45 $6.72
Average True Range (ATR) 0.14 0.63
MACD -0.01 0.12
Stochastic Oscillator 0.97 73.10

Price Performance

Historical Comparison
HCAT
ACOG

About HCAT Health Catalyst Inc

Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platforms, analytics applications, and support services. This generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: